Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Hepatitis B Virus Infection on the Clinical Course of Inflammatory Bowel Disease in Egyptian Patients

NCT06881238 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT06881238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06881238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Hepatitis B Virus Infection on the Clinical Course of Inflammatory Bowel Disease in Egyptian Patients
Lead sponsor
Tanta University
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2024
Completion date
June 10, 2025
Enrollment
162 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b virus, inflammatory bowel disease (ibd)